Vulvar High-grade Squamous Intraepithelial Lesions

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-03-18
Clinical Trial Update: Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions [Phase 2]
Phase 2 trial investigating E7 T cell receptor T cells for vulvar high-grade squamous intraepithelial lesions (HSIL) by NCI; study terminate…